Coherus Oncology will report earnings after the market closes. View Calendar The market is expecting a ±14.2% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±9.0%. View Expected Move (Conf Call: Nov 9 5:00 PM)
Coherus Oncology trades 2,291 contracts. CHRS will report earnings on Nov 9, 2026. The company has the following event: Coherus Oncology Webcast to Disclose Interim Tagmokitug Clinical Data on Oct 28, 2026.
Coherus Oncology trades 2,613 contracts. CHRS will report earnings on Nov 9, 2026. The company has the following event: Coherus Oncology Webcast to Disclose Interim Tagmokitug Clinical Data on Oct 28, 2026. News: Coherus to Participate in Upcoming Investor Conferences
Coherus Oncology will report earnings after the market closes. View Calendar The market is expecting a ±11.6% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±9.3%. View Expected Move (Conf Call: May 11 5:00 PM)
$CHRS Earnings March 09 AMC. Options Imply ±16.5% Move. Shares gained +42.5% since the last report
